Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 2/2013

01-04-2013 | Letter

Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis' - authors' reply

Authors: Qin Shi, Jamilah Abusarah, Ghayath Baroudi, Julio C Fernandes, Hassan Fahmi, Mohamed Benderdour

Published in: Arthritis Research & Therapy | Issue 2/2013

Login to get access

Excerpt

We thank Wang and colleagues for their comments [1] about our recent study [2] and would like to make two points to clarify our reasoning. …
Literature
1.
Wang D, Hu S, Wei W: Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis'. Arthritis Res Ther. 2013, 15: 405-10.1186/ar4195.PubMedCentralCrossRefPubMed
2.
Shi Q, Abusarah J, Baroudi G, Fernandes JC, Fahmi H, Benderdour M: Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis. Arthritis Res Ther. 2012, 14: R223-10.1186/ar4062.PubMedCentralCrossRefPubMed
3.
Fernandes JC, Wang H, Jreyssaty C, Benderdour M, Lavigne P, Qiu X, Winnik FM, Zhang X, Dai K, Shi Q: Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. Mol Ther. 2008, 16: 1243-1251. 10.1038/mt.2008.99.CrossRefPubMed
4.
Lu Y, Stinnette TW, Westrick E, Klein PJ, Gehrke MA, Cross VA, Vlahov IR, Low PS, Leamon CP: Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate. Arthritis Res Ther. 2011, 13: R56-10.1186/ar3304.PubMedCentralCrossRefPubMed
5.
Coulthard LG, Costello J, Robinson B, Shiels IA, Taylor SM, Woodruff TM: Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis. Arthritis Res Ther. 2011, 13: R42-10.1186/ar3278.PubMedCentralCrossRefPubMed
6.
Du F, Lü LJ, Fu Q, Dai M, Teng JL, Fan W, Chen SL, Ye P, Shen N, Huang XF, Qian J, Bao CD: T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis. Arthritis Res Ther. 2008, 10: R136-10.1186/ar2554.PubMedCentralCrossRefPubMed
7.
Le Goff B, Soltner E, Charrier C, Maugars Y, Rédini F, Heymann D, Berthelot JM: A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. Arthritis Res Ther. 2009, 11: R185-10.1186/ar2877.PubMedCentralCrossRefPubMed
8.
Boettger MK, Leuchtweis J, Kümmel D, Gajda M, Bräuer R, Schaible HG: Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. Arthritis Res Ther. 2010, 12: R140-10.1186/ar3079.PubMedCentralCrossRefPubMed
9.
Ahmed AS, Li J, Ahmed M, Hua L, Yakovleva T, Ossipov MH, Bakalkin G, Stark A: Attenuation of pain and inflammation in adjuvant-induced arthritis by the proteasome inhibitor MG132. Arthritis Rheum. 2010, 62: 2160-2169.PubMed
10.
Lauzier A, Charbonneau M, Harper K, Jilaveanu-Pelmus M, Dubois CM: Formation of invadopodia-like structures by synovial cells promotes cartilage breakdown in collagen-induced arthritis: involvement of the protein tyrosine kinase Src. Arthritis Rheum. 2011, 63: 1591-1602. 10.1002/art.30305.CrossRefPubMed
11.
Clark AK, Grist J, Al-Kashi A, Perretti M, Malcangio M: Spinal cathepsin S and fractalkine contribute to chronic pain in the collagen-induced arthritis model. Arthritis Rheum. 2012, 64: 2038-2047. 10.1002/art.34351.CrossRefPubMed
12.
Berkenboom G, Langer I, Carpentier Y, Grosfils K, Fontaine J: Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism. Hypertension. 1997, 30 (3 Pt 1): 371-376.CrossRefPubMed
13.
Moinuddin G, Inamdar MN, Kulkarni KS, Kulkarni C: Modulation of hemodynamics, endogenous antioxidant enzymes, and pathophysiological changes by Angiotensin-converting enzyme inhibitors in pressure-overload rats. Hellenic J Cardiol. 2011, 52: 216-226.PubMed
14.
Raasch W, Jöhren O, Schwartz S, Gieselberg A, Dominiak P: Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. J Hypertens. 2004, 22: 611-618. 10.1097/00004872-200403000-00025.CrossRefPubMed
Metadata
Title
Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis' - authors' reply
Authors
Qin Shi
Jamilah Abusarah
Ghayath Baroudi
Julio C Fernandes
Hassan Fahmi
Mohamed Benderdour
Publication date
01-04-2013
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2013
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4196

Other articles of this Issue 2/2013

Arthritis Research & Therapy 2/2013 Go to the issue

Research article

Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes

Research article

Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women

Research article

Association between alcohol consumption and symptom severity and quality of life in patients with fibromyalgia

Research article

Treatment of rheumatoid arthritis in the Medicare Current Beneficiary Survey

Editorial

Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?

Research article

Germline deletion of β2 microglobulin or CD1d reduces anti-phospholipid antibody, but increases autoantibodies against non-phospholipid antigens in the NZB/W F1 model of lupus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits